Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 82868-045, Hydralazine Hydrochloride, tablet, from Northwind Health Company, LLC.

Product NDC
82868-045
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82868-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
82868-045-308286800453030 TABLET in 1 BOTTLE, PLASTIC (82868-045-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1275dd50-d97f-2e8f-e063-6394a90a4a67

Use it

Look up 82868-045 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82868-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82868-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.